Quantitative approaches to drug development
We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives. Science and Services
About
Pharmetheus reduces uncertainty in all phases of drug development.
News
The findings demonstrate that crovalimab achieves complete terminal complement activity inhibition, provides effective disease control, and maintains a safety profile comparable to existing C5 inhibitors. Notably, the study also highlights crovalimab’s potential to reduce treatment burden, offering a promising avenue for improving care in PNH.
UPSS 2024 participant Karam Alali, originally from Syria, began his academic journey studying pharmacy and biotechnology before transitioning to pharmacometrics during his Ph.D. in Malaysia. “The integration of math and pharmacy is what excites me most,” Karam explains. “Using programming and mathematical models to predict drug behavior felt like the perfect blend of my interests.” “The UPSS experience was really…
Ida Neldemo reflects on her journey as a MIDD consultant at Pharmetheus and how integrity shapes every client interaction.
How we work
Traceability, accountability, and independent quality control are of utmost importance to us, and embedded in our way of working.
Publications
Explore our scientific publications.
Explore our web
Model Informed Drug Development
A quantitative framework to support and inform development program strategies and decisions.
“Sharing with colleagues is why I love working here”
Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.
History of Pharmetheus
Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.